Allena Pharmaceuticals, Inc.
ALNAQ · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $19 | $21 | $45 | $69 |
| - Cash | $7 | $9 | $30 | $40 |
| + Debt | $0 | $5 | $1 | $10 |
| Enterprise Value | $13 | $17 | $16 | $39 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$11 | $5 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$12 | $6 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.085 | -0.13 | 0.074 | -0.17 |
| % Growth | 34.6% | -275.4% | 143.6% | – |
| Operating Cash Flow | -$5 | -$20 | -$13 | -$11 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$20 | -$13 | -$12 |